Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Pirisi

Showing results (171-180 of 255) with videos related to

Pageof 26
Sort By:
Biomarkers in Medicine|December 16, 2017
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver diseaseMattia Bellan, Pier Paolo Sainaghi, Margherita Tran Minh, et al.
European Journal of Gastroenterology & Hepatology|May 25, 2017
Etiological factors of chronic hepatitis in Italy: a 2014 national surveyTommaso Stroffolini, Evangelista Sagnelli, Piero L Almasio, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related DiseasesMattia Bellan, Ailia Giubertoni, Cristina Piccinino, et al.
Viruses|June 27, 2024
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus InfectionMaria Grazia Crobu, Paolo Ravanini, Clotilde Impaloni, et al.
Frontiers in Psychiatry|July 5, 2022
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-UpCarla Gramaglia, Eleonora Gattoni, Eleonora Gambaro, et al.
Oncotarget|June 1, 2016
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative studyDavid J Pinato, Tadaaki Arizumi, Jeong Won Jang, et al.
Oncotarget|February 18, 2017
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenibJessica Howell, David J Pinato, Ramya Ramaswami, et al.
Gastroenterology Research and Practice|May 9, 2020
Interplay of <i>PNPLA3</i> and <i>HSD17B13</i> Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C PatientsCarla De Benedittis, Mattia Bellan, Martina Crevola, et al.
Clinical Rheumatology|November 13, 2019
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritisMattia Bellan, Erinda Puta, Alessandro Croce, et al.
World Journal of Gastrointestinal Surgery|October 8, 2021
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatmentFrancesca Carissimi, Matteo Nazzareno Barbaglia, Livia Salmi, et al.
Pageof 26

Showing results (171-180 of 255) with videos related to

Sort By:
Pageof 26
Biomarkers in Medicine|December 16, 2017
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver diseaseMattia Bellan, Pier Paolo Sainaghi, Margherita Tran Minh, et al.
European Journal of Gastroenterology & Hepatology|May 25, 2017
Etiological factors of chronic hepatitis in Italy: a 2014 national surveyTommaso Stroffolini, Evangelista Sagnelli, Piero L Almasio, et al.
Pharmaceuticals (Basel, Switzerland)|April 30, 2021
Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related DiseasesMattia Bellan, Ailia Giubertoni, Cristina Piccinino, et al.
Viruses|June 27, 2024
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus InfectionMaria Grazia Crobu, Paolo Ravanini, Clotilde Impaloni, et al.
Frontiers in Psychiatry|July 5, 2022
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-UpCarla Gramaglia, Eleonora Gattoni, Eleonora Gambaro, et al.
Oncotarget|June 1, 2016
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative studyDavid J Pinato, Tadaaki Arizumi, Jeong Won Jang, et al.
Oncotarget|February 18, 2017
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenibJessica Howell, David J Pinato, Ramya Ramaswami, et al.
Gastroenterology Research and Practice|May 9, 2020
Interplay of <i>PNPLA3</i> and <i>HSD17B13</i> Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C PatientsCarla De Benedittis, Mattia Bellan, Martina Crevola, et al.
Clinical Rheumatology|November 13, 2019
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritisMattia Bellan, Erinda Puta, Alessandro Croce, et al.
World Journal of Gastrointestinal Surgery|October 8, 2021
Finding the seed of recurrence: Hepatocellular carcinoma circulating tumor cells and their potential to drive the surgical treatmentFrancesca Carissimi, Matteo Nazzareno Barbaglia, Livia Salmi, et al.
Pageof 26